- ►diabetesjournals.org M Wolzt, A de la Peña, PY Berclaz, FS Tibaldi, JR … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—AIR insulin exposure was reduced 34 and 41% (both P < 0.01) in asthmatic subjects
(area under the curve 0-t′ , 24.0 and 21.1 nmol · min · l −1 in mild and moderate asthma
subjects, respectively) compared with healthy subjects (35.2 nmol · min · l −1 ), ... Cited by 4 - Related articles - BL Direct - All 4 versions
[CITATION] Effects of albuterol and fluticasone on inhaled human insulin (Exubera) …
JG Teeter, R Foutaine, A Milton, G Wei, T Checchio, M … - … of this article were presented in …, 2006 Cited by 3 - Related articles
AX Pan, A de la Peña, KP Yeo, C Chan, … - British Journal of …, 2008 - pubmedcentral.nih.gov Nondiabetic smokers (n = 24) with normal pulmonary function completed a two-phase
(four-period), open-label, randomized euglycaemic clamp study. During the initial study
phase, subjects underwent glucose clamps following AIR Insulin dosing, shortly after ... Cited by 3 - Related articles - BL Direct - All 4 versions
JH DeVries - Diabetologia, 2005 - Springer To the Editor: Recently, two Phase 3 Exubera inhaled insulin trials in type 1 diabetes and a Phase
2 AERx inhaled insulin trial in type 2 diabetes were reported. No overall difference in HbA 1 c
was noted, but fasting plasma glucose was lower in the inhaled insulin group in all three ... Cited by 5 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org K Rave, A de la Peña, FS Tibaldi, L Zhang, B … - Diabetes care, 2007 - Am Diabetes Assoc RESULTS— In subjects with chronic bronchitis and emphysema, AIR inhaled insulin administration
resulted in reduced insulin exposure (area under the serum insulin concentration curve from
time zero until time of return to baseline [AUC 0–t′ ]) (55.7%, P = 0.13 and 78.5%, P < ... Cited by 16 - Related articles - BL Direct - All 6 versions
BL Silverman, CJ Barnes, BN Campaigne, … - Vascular Health and …, 2007 - pubmedcentral.nih.gov Diabetes mellitus is a significant worldwide health problem, with the incidence of type 2 diabetes
increasing at alarming rates. Insulin resistance and dysregulated blood glucose control are established
risk factors for microvascular complications and cardiovascular disease. Despite the ... Cited by 1 - Related articles - BL Direct - All 8 versions
J Wright - Clinical Research and Regulatory Affairs, 2001 - informahealthcare.com The deamidation reaction is primarily the result of the hydrolysis of asparagine to aspartic
acid. Thus, the reaction is most likely to proceed in an aqueous environment. If the protein is
formulated in the solid state, the reaction rate is minimized. As discussed in Chapter 2, ... Cited by 1 - Related articles - BL Direct - All 7 versions
E Ang, MK Lawrence, CR Heilmann, JA … - Diabetes Technology …, 2009 - liebertonline.com Abstract Background: Long-term safety and efficacy of AIRÒ inhaled insulin (Eli Lilly and
Co., Indianapolis, IN) (AIR is a registered trademark of Alkermes, Inc., Cambridge, MA) in patients
with diabetes and concomitant lung disease remain to be established. Methods: This ... Cited by 1 - Related articles - All 2 versions
A de la Pena, M Seger, K Rave, L Heinemann … - Diabetes Technology …, 2009 - liebertonline.com Abstract Background: In order to assess pharmacokinetic (PK) and glucodynamic (GD) attributes
relevant to the end user of an inhaled insulin, this study examined the exposure and GD effect
of doses of AIRÒ inhaled insulin (Eli Lilly and Co., Indianapolis, IN) (AIR is a registered ... Cited by 1 - Related articles - All 3 versions
- ►chestjournal.org [PDF] KIK Yoshioka, BL Laube, GW Benedict, AS Dobs - Chest, 1999 - Am Coll Chest Phys Communications for this section will be published as space and priorities permit. The comments
should not exceed 350 words in length, with a maximum of five references; one figure or table
can be printed. Exceptions may occur under particular circum- stances. Contributions may ... Cited by 1 - Related articles - All 4 versions
